APO Research
Talk to an analyst

APO RESEARCH · REPORT

Artemisinin

Artemisinin is a sesquiterpene lactone containing an unusual peroxide bridge which possesses the most rapid action of all current drugs against Plasmodium falciparum malaria. It is isolated from the plant Artemisia annua, sweet wormwood, an herb employed in Chinese traditional medicine. It can now also be produced using genetically engineered yeast.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Artemisinin is a sesquiterpene lactone containing an unusual peroxide bridge which possesses the most rapid action of all current drugs against Plasmodium falciparum malaria. It is isolated from the plant Artemisia annua, sweet wormwood, an herb employed in Chinese traditional medicine. It can now also be produced using genetically engineered yeast.

Selected research

Industry Growth & Trends

Global Artemisinin Industry Growth and Trends Forecast to 2032

20 December 2025106 pages

Choose your research edition.

Industry ResearchArtemisinin Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Artemisinin Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Artemisinin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Artemisinin Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Artemisinin Market Analysis and Forecast 2026-2032217 pages · $4,950 USD

Market perspective

Artemisinin is a sesquiterpene lactone containing an unusual peroxide bridge which possesses the most rapid action of all current drugs against Plasmodium falciparum malaria. It is isolated from the plant Artemisia annua, sweet wormwood, an herb employed in Chinese traditional medicine. It can now also be produced using genetically engineered yeast.

Global Artemisinin key players include KPC Pharmaceuticals, Kerui nanhai, Sanofi, Guangxi xiancaotang, etc. Global top four manufacturers hold a share over 65%.

Europe is the largest market, with a share about 45%, followed by India, and Africa, both have a share about 40 percent.

Read the full market overview

In terms of product, Extraction from Artemisia annua is the largest segment, with a share over 80%. And in terms of application, the largest application is Antimalarial Tablets, followed by Antimalarial Injections.

Report Scope

This report provides a structured, data-driven view of the global Artemisinin market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Artemisinin market size, estimates, and forecasts are presented in terms of sales volume (MT) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Artemisinin market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Artemisinin.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Artemisinin market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Artemisinin Market by Company

Sanofi

KPC Pharmaceuticals

Kerui nanhai

Guangxi xiancaotang

Guilin Pharmaceutical

Natural Bio-engineering

BIONEXX

CAT KHANH

BEEPZ

Novanat Bioresource

Artemisinin Segment by Type

Extraction From Artemisia Annua

Semisynthetic Artemisinin

Artemisinin Segment by Application

Antimalarial Injections

Antimalarial Tablets

Artemisinin Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Artemisinin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Artemisinin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Artemisinin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Artemisinin manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Artemisinin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Extraction From Artemisia Annua Table 2. Major Company of Semisynthetic Artemisinin Table 3. Global Artemisinin Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Artemisinin Sales by Type (2021-2026) & (MT) Table 5. Global Artemisinin Sales Market Share in Volume by Type (2021-2026) Table 6. Global Artemisinin Sales by Type (2021-2026) & (US$ Million) Table 7. Global Artemisinin Sales Market Share in Value by Type (2021-2026) Table 8. Global Artemisinin Price by Type (2021-2026) & (USD/MT) Table 9. Global Artemisinin Sales by Type (2027-2032) & (MT) Table 10. Global Artemisinin Sales Market Share in Volume by Type (2027-2032) Table 11. Global Artemisinin Sales by Type (2027-2032) & (US$ Million) Table 12. Global Artemisinin Sales Market Share in Value by Type (2027-2032) Table 13. Global Artemisinin Price by Type (2027-2032) & (USD/MT) Table 14. North America Artemisinin Sales by Type (2021-2026) & (MT) Table 15. North America Artemisinin Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Artemisinin Sales by Type (2021-2026) & (MT) Table 17. Europe Artemisinin Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Artemisinin Sales by Type (2021-2026) & (MT) Table 19. Asia-Pacific Artemisinin Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Artemisinin Sales by Type (2021-2026) & (MT) Table 21. Latin America Artemisinin Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Artemisinin Sales by Type (2021-2026) & (MT) Table 23. Middle East and Africa Artemisinin Sales by Type (2021-2026) & (US$ Million) Table 24. Artemisinin Industry Trends Table 25. Artemisinin Industry Drivers Table 26. Artemisinin Industry Opportunities and Challenges Table 27. Artemisinin Industry Restraints Table 28. Global Artemisinin Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Artemisinin Revenue Market Share by Company (2021-2026) Table 30. Global Artemisinin Sales by Company (2021-2026) & (MT) Table 31. Global Artemisinin Sales Share by Company (2021-2026) Table 32. Global Artemisinin Market Price by Company (2021-2026) & (USD/MT) Table 33. Global Artemisinin Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Artemisinin Major Company Production Sites and Headquarters Table 35. Global Artemisinin Company, Product Type & Application Table 36. Global Artemisinin Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Artemisinin by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Artemisinin Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Artemisinin Sales by Region (2021-2026) & (MT) Table 41. Global Artemisinin Sales Market Share in Volume by Region (2021-2026) Table 42. Global Artemisinin Sales by Region (2021-2026) & (US$ Million) Table 43. Global Artemisinin Sales Market Share in Value by Region (2021-2026) Table 44. Global Artemisinin Sales (MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 45. Global Artemisinin Sales by Region (2027-2032) & (MT) Table 46. Global Artemisinin Sales Market Share in Volume by Region (2027-2032) Table 47. Global Artemisinin Sales by Region (2027-2032) & (US$ Million) Table 48. Global Artemisinin Sales Market Share in Value by Region (2027-2032) Table 49. Global Artemisinin Sales (MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2027-2032) Table 50. Global Artemisinin Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Artemisinin Sales by Application (2021-2026) & (MT) Table 52. Global Artemisinin Sales Market Share in Volume by Application (2021-2026) Table 53. Global Artemisinin Sales by Application (2021-2026) & (US$ Million) Table 54. Global Artemisinin Sales Market Share in Value by Application (2021-2026) Table 55. Global Artemisinin Price by Application (2021-2026) & (USD/MT) Table 56. Global Artemisinin Sales by Application (2027-2032) & (MT) Table 57. Global Artemisinin Sales Market Share in Volume by Application (2027-2032) Table 58. Global Artemisinin Sales by Application (2027-2032) & (US$ Million) Table 59. Global Artemisinin Sales Market Share in Value by Application (2027-2032) Table 60. Global Artemisinin Price by Application (2027-2032) & (USD/MT) Table 61. North America Artemisinin Sales by Application (2021-2026) & (MT) Table 62. North America Artemisinin Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Artemisinin Sales by Application (2021-2026) & (MT) Table 64. Europe Artemisinin Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Artemisinin Sales by Application (2021-2026) & (MT) Table 66. Asia-Pacific Artemisinin Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Artemisinin Sales by Application (2021-2026) & (MT) Table 68. Latin America Artemisinin Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Artemisinin Sales by Application (2021-2026) & (MT) Table 70. Middle East and Africa Artemisinin Sales by Application (2021-2026) & (US$ Million) Table 71. Sanofi Company Information Table 72. Sanofi Business Overview Table 73. Sanofi Artemisinin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 74. Sanofi Artemisinin Product Portfolio Table 75. Sanofi Recent Development Table 76. KPC Pharmaceuticals Company Information Table 77. KPC Pharmaceuticals Business Overview Table 78. KPC Pharmaceuticals Artemisinin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 79. KPC Pharmaceuticals Artemisinin Product Portfolio Table 80. KPC Pharmaceuticals Recent Development Table 81. Kerui nanhai Company Information Table 82. Kerui nanhai Business Overview Table 83. Kerui nanhai Artemisinin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 84. Kerui nanhai Artemisinin Product Portfolio Table 85. Kerui nanhai Recent Development Table 86. Guangxi xiancaotang Company Information Table 87. Guangxi xiancaotang Business Overview Table 88. Guangxi xiancaotang Artemisinin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 89. Guangxi xiancaotang Artemisinin Product Portfolio Table 90. Guangxi xiancaotang Recent Development Table 91. Guilin Pharmaceutical Company Information Table 92. Guilin Pharmaceutical Business Overview Table 93. Guilin Pharmaceutical Artemisinin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 94. Guilin Pharmaceutical Artemisinin Product Portfolio Table 95. Guilin Pharmaceutical Recent Development Table 96. Natural Bio-engineering Company Information Table 97. Natural Bio-engineering Business Overview Table 98. Natural Bio-engineering Artemisinin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 99. Natural Bio-engineering Artemisinin Product Portfolio Table 100. Natural Bio-engineering Recent Development Table 101. BIONEXX Company Information Table 102. BIONEXX Business Overview Table 103. BIONEXX Artemisinin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 104. BIONEXX Artemisinin Product Portfolio Table 105. BIONEXX Recent Development Table 106. CAT KHANH Company Information Table 107. CAT KHANH Business Overview Table 108. CAT KHANH Artemisinin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 109. CAT KHANH Artemisinin Product Portfolio Table 110. CAT KHANH Recent Development Table 111. BEEPZ Company Information Table 112. BEEPZ Business Overview Table 113. BEEPZ Artemisinin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 114. BEEPZ Artemisinin Product Portfolio Table 115. BEEPZ Recent Development Table 116. Novanat Bioresource Company Information Table 117. Novanat Bioresource Business Overview Table 118. Novanat Bioresource Artemisinin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 119. Novanat Bioresource Artemisinin Product Portfolio Table 120. Novanat Bioresource Recent Development Table 121. North America Artemisinin Market Size Growth Rate (CAGR) by Country (MT): 2021 VS 2025 VS 2032 Table 122. North America Artemisinin Sales by Country (2021-2026) & (MT) Table 123. North America Artemisinin Sales Market Share by Country (2021-2026) Table 124. North America Artemisinin Sales Forecast by Country (2027-2032) & (MT) Table 125. North America Artemisinin Sales Market Share Forecast by Country (2027-2032) Table 126. North America Artemisinin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. North America Artemisinin Market Size by Country (2021-2026) & (US$ Million) Table 128. North America Artemisinin Market Share by Country (2021-2026) Table 129. North America Artemisinin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. North America Artemisinin Market Share Forecast by Country (2027-2032) Table 131. Europe Artemisinin Market Size Growth Rate (CAGR) by Country (MT): 2021 VS 2025 VS 2032 Table 132. Europe Artemisinin Sales by Country (2021-2026) & (MT) Table 133. Europe Artemisinin Sales Market Share by Country (2021-2026) Table 134. Europe Artemisinin Sales Forecast by Country (2027-2032) & (MT) Table 135. Europe Artemisinin Sales Market Share Forecast by Country (2027-2032) Table 136. Europe Artemisinin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Europe Artemisinin Market Size by Country (2021-2026) & (US$ Million) Table 138. Europe Artemisinin Market Share by Country (2021-2026) Table 139. Europe Artemisinin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Europe Artemisinin Market Share Forecast by Country (2027-2032) Table 141. Asia-Pacific Artemisinin Market Size Growth Rate (CAGR) by Country (MT): 2021 VS 2025 VS 2032 Table 142. Asia-Pacific Artemisinin Sales by Country (2021-2026) & (MT) Table 143. Asia-Pacific Artemisinin Sales Market Share by Country (2021-2026) Table 144. Asia-Pacific Artemisinin Sales Forecast by Country (2027-2032) & (MT) Table 145. Asia-Pacific Artemisinin Sales Market Share Forecast by Country (2027-2032) Table 146. Asia-Pacific Artemisinin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Asia-Pacific Artemisinin Market Size by Country (2021-2026) & (US$ Million) Table 148. Asia-Pacific Artemisinin Market Share by Country (2021-2026) Table 149. Asia-Pacific Artemisinin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Asia-Pacific Artemisinin Market Share Forecast by Country (2027-2032) Table 151. Latin America Artemisinin Market Size Growth Rate (CAGR) by Country (MT): 2021 VS 2025 VS 2032 Table 152. Latin America Artemisinin Sales by Country (2021-2026) & (MT) Table 153. Latin America Artemisinin Sales Market Share by Country (2021-2026) Table 154. Latin America Artemisinin Sales Forecast by Country (2027-2032) & (MT) Table 155. Latin America Artemisinin Sales Market Share Forecast by Country (2027-2032) Table 156. Latin America Artemisinin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Latin America Artemisinin Market Size by Country (2021-2026) & (US$ Million) Table 158. Latin America Artemisinin Market Share by Country (2021-2026) Table 159. Latin America Artemisinin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Latin America Artemisinin Market Share Forecast by Country (2027-2032) Table 161. Middle East and Africa Artemisinin Market Size Growth Rate (CAGR) by Country (MT): 2021 VS 2025 VS 2032 Table 162. Middle East and Africa Artemisinin Sales by Country (2021-2026) & (MT) Table 163. Middle East and Africa Artemisinin Sales Market Share by Country (2021-2026) Table 164. Middle East and Africa Artemisinin Sales Forecast by Country (2027-2032) & (MT) Table 165. Middle East and Africa Artemisinin Sales Market Share Forecast by Country (2027-2032) Table 166. Middle East and Africa Artemisinin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Middle East and Africa Artemisinin Market Size by Country (2021-2026) & (US$ Million) Table 168. Middle East and Africa Artemisinin Market Share by Country (2021-2026) Table 169. Middle East and Africa Artemisinin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Middle East and Africa Artemisinin Market Share Forecast by Country (2027-2032) Table 171. Key Raw Materials Table 172. Raw Materials Key Suppliers Table 173. Artemisinin Distributors List Table 174. Artemisinin Customers List Table 175. Research Programs/Design for This Report Table 176. Authors List of This Report Table 177. Secondary Sources Table 178. Primary Sources List of Figures Figure 1. Artemisinin Image Figure 2. Global Artemisinin Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Artemisinin Market Size (2021-2032) & (US$ Million) Figure 4. Global Artemisinin Sales (2021-2032) & (MT) Figure 5. Extraction From Artemisia Annua Image Figure 6. Global Extraction From Artemisia Annua Sales YoY Growth (2021-2032) & (MT) Figure 7. Semisynthetic Artemisinin Image Figure 8. Global Semisynthetic Artemisinin Sales YoY Growth (2021-2032) & (MT) Figure 9. Global Artemisinin Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Artemisinin Market Share by Type 2025 VS 2032 Figure 11. North America Artemisinin Sales Market Share in Volume by Type in 2025 Figure 12. North America Artemisinin Sales Market Share in Value by Type in 2025 Figure 13. Europe Artemisinin Sales Market Share in Volume by Type in 2025 Figure 14. Europe Artemisinin Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Artemisinin Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Artemisinin Sales Market Share in Value by Type in 2025 Figure 17. Latin America Artemisinin Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Artemisinin Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Artemisinin Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Artemisinin Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Artemisinin Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Antimalarial Injections Image Figure 24. Global Antimalarial Injections Sales YoY Growth (2021-2032) & (MT) Figure 25. Antimalarial Tablets Image Figure 26. Global Antimalarial Tablets Sales YoY Growth (2021-2032) & (MT) Figure 27. Global Artemisinin Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Artemisinin Market Share by Application 2025 VS 2032 Figure 29. North America Artemisinin Sales Market Share in Volume by Application in 2025 Figure 30. North America Artemisinin Sales Market Share in Value by Application in 2025 Figure 31. Europe Artemisinin Sales Market Share in Volume by Application in 2025 Figure 32. Europe Artemisinin Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Artemisinin Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Artemisinin Sales Market Share in Value by Application in 2025 Figure 35. Latin America Artemisinin Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Artemisinin Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Artemisinin Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Artemisinin Sales Market Share in Value by Application in 2025 Figure 39. North America Artemisinin Sales by Country: 2021 VS 2025 VS 2032 (MT) Figure 40. North America Artemisinin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Artemisinin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Artemisinin Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Artemisinin Sales by Country: 2021 VS 2025 VS 2032 (MT) Figure 44. Europe Artemisinin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Artemisinin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Artemisinin Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Artemisinin Sales by Country: 2021 VS 2025 VS 2032 (MT) Figure 48. Asia-Pacific Artemisinin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Artemisinin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Artemisinin Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Artemisinin Sales by Country: 2021 VS 2025 VS 2032 (MT) Figure 52. Latin America Artemisinin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Artemisinin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Artemisinin Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Artemisinin Sales by Country: 2021 VS 2025 VS 2032 (MT) Figure 56. Middle East and Africa Artemisinin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Artemisinin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Artemisinin Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Artemisinin Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Artemisinin Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Extraction From Artemisia Annua
  • Semisynthetic Artemisinin
Applications
  • Antimalarial Injections
  • Antimalarial Tablets
Companies covered
  • Sanofi
  • KPC Pharmaceuticals
  • Kerui nanhai
  • Guangxi xiancaotang
  • Guilin Pharmaceutical
  • Natural Bio-engineering
  • BIONEXX
  • CAT KHANH
  • BEEPZ
  • Novanat Bioresource

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Artemisinin Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Artemisinin Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Artemisinin Market by Type
  6. 1.3.1 Extraction From Artemisia Annua
  7. 1.3.2 Semisynthetic Artemisinin
  8. 1.4 Global Artemisinin Market Size by Type
  9. 1.4.1 Global Artemisinin Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Artemisinin Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Artemisinin Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Artemisinin Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Artemisinin Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Artemisinin Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Artemisinin Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Artemisinin Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Artemisinin Industry Trends
  2. 2.2 Artemisinin Industry Drivers
  3. 2.3 Artemisinin Industry Opportunities and Challenges
  4. 2.4 Artemisinin Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Artemisinin Revenue (2021-2026)
  2. 3.2 Global Top Players by Artemisinin Sales (2021-2026)
  3. 3.3 Global Top Players by Artemisinin Price (2021-2026)
  4. 3.4 Global Artemisinin Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Artemisinin Major Company Production Sites & Headquarters
  6. 3.6 Global Artemisinin Company, Product Type & Application
  7. 3.7 Global Artemisinin Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Artemisinin Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Artemisinin Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Artemisinin Tier 1, Tier 2, and Tier 3
4 Artemisinin Regional Status and Outlook
  1. 4.1 Global Artemisinin Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Artemisinin Historic Market Size by Region
  3. 4.2.1 Global Artemisinin Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Artemisinin Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Artemisinin Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Artemisinin Forecasted Market Size by Region
  7. 4.3.1 Global Artemisinin Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Artemisinin Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Artemisinin Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Artemisinin by Application
  1. 5.1 Artemisinin Market by Application
  2. 5.1.1 Antimalarial Injections
  3. 5.1.2 Antimalarial Tablets
  4. 5.2 Global Artemisinin Market Size by Application
  5. 5.2.1 Global Artemisinin Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Artemisinin Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Artemisinin Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Artemisinin Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Artemisinin Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Artemisinin Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Artemisinin Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Artemisinin Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Sanofi
  2. 6.1.1 Sanofi Company Information
  3. 6.1.2 Sanofi Business Overview
  4. 6.1.3 Sanofi Artemisinin Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Sanofi Artemisinin Product Portfolio
  6. 6.1.5 Sanofi Recent Developments
  7. 6.2 KPC Pharmaceuticals
  8. 6.2.1 KPC Pharmaceuticals Company Information
  9. 6.2.2 KPC Pharmaceuticals Business Overview
  10. 6.2.3 KPC Pharmaceuticals Artemisinin Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 KPC Pharmaceuticals Artemisinin Product Portfolio
  12. 6.2.5 KPC Pharmaceuticals Recent Developments
  13. 6.3 Kerui nanhai
  14. 6.3.1 Kerui nanhai Company Information
  15. 6.3.2 Kerui nanhai Business Overview
  16. 6.3.3 Kerui nanhai Artemisinin Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Kerui nanhai Artemisinin Product Portfolio
  18. 6.3.5 Kerui nanhai Recent Developments
  19. 6.4 Guangxi xiancaotang
  20. 6.4.1 Guangxi xiancaotang Company Information
  21. 6.4.2 Guangxi xiancaotang Business Overview
  22. 6.4.3 Guangxi xiancaotang Artemisinin Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Guangxi xiancaotang Artemisinin Product Portfolio
  24. 6.4.5 Guangxi xiancaotang Recent Developments
  25. 6.5 Guilin Pharmaceutical
  26. 6.5.1 Guilin Pharmaceutical Company Information
  27. 6.5.2 Guilin Pharmaceutical Business Overview
  28. 6.5.3 Guilin Pharmaceutical Artemisinin Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Guilin Pharmaceutical Artemisinin Product Portfolio
  30. 6.5.5 Guilin Pharmaceutical Recent Developments
  31. 6.6 Natural Bio-engineering
  32. 6.6.1 Natural Bio-engineering Company Information
  33. 6.6.2 Natural Bio-engineering Business Overview
  34. 6.6.3 Natural Bio-engineering Artemisinin Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Natural Bio-engineering Artemisinin Product Portfolio
  36. 6.6.5 Natural Bio-engineering Recent Developments
  37. 6.7 BIONEXX
  38. 6.7.1 BIONEXX Company Information
  39. 6.7.2 BIONEXX Business Overview
  40. 6.7.3 BIONEXX Artemisinin Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 BIONEXX Artemisinin Product Portfolio
  42. 6.7.5 BIONEXX Recent Developments
  43. 6.8 CAT KHANH
  44. 6.8.1 CAT KHANH Company Information
  45. 6.8.2 CAT KHANH Business Overview
  46. 6.8.3 CAT KHANH Artemisinin Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 CAT KHANH Artemisinin Product Portfolio
  48. 6.8.5 CAT KHANH Recent Developments
  49. 6.9 BEEPZ
  50. 6.9.1 BEEPZ Company Information
  51. 6.9.2 BEEPZ Business Overview
  52. 6.9.3 BEEPZ Artemisinin Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 BEEPZ Artemisinin Product Portfolio
  54. 6.9.5 BEEPZ Recent Developments
  55. 6.10 Novanat Bioresource
  56. 6.10.1 Novanat Bioresource Company Information
  57. 6.10.2 Novanat Bioresource Business Overview
  58. 6.10.3 Novanat Bioresource Artemisinin Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Novanat Bioresource Artemisinin Product Portfolio
  60. 6.10.5 Novanat Bioresource Recent Developments
7 North America by Country
  1. 7.1 North America Artemisinin Sales by Country
  2. 7.1.1 North America Artemisinin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Artemisinin Sales by Country (2021-2026)
  4. 7.1.3 North America Artemisinin Sales Forecast by Country (2027-2032)
  5. 7.2 North America Artemisinin Market Size by Country
  6. 7.2.1 North America Artemisinin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Artemisinin Market Size by Country (2021-2026)
  8. 7.2.3 North America Artemisinin Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Artemisinin Sales by Country
  2. 8.1.1 Europe Artemisinin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Artemisinin Sales by Country (2021-2026)
  4. 8.1.3 Europe Artemisinin Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Artemisinin Market Size by Country
  6. 8.2.1 Europe Artemisinin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Artemisinin Market Size by Country (2021-2026)
  8. 8.2.3 Europe Artemisinin Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Artemisinin Sales by Country
  2. 9.1.1 Asia-Pacific Artemisinin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Artemisinin Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Artemisinin Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Artemisinin Market Size by Country
  6. 9.2.1 Asia-Pacific Artemisinin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Artemisinin Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Artemisinin Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Artemisinin Sales by Country
  2. 10.1.1 South America Artemisinin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Artemisinin Sales by Country (2021-2026)
  4. 10.1.3 South America Artemisinin Sales Forecast by Country (2027-2032)
  5. 10.2 South America Artemisinin Market Size by Country
  6. 10.2.1 South America Artemisinin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Artemisinin Market Size by Country (2021-2026)
  8. 10.2.3 South America Artemisinin Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Artemisinin Sales by Country
  2. 11.1.1 Middle East and Africa Artemisinin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Artemisinin Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Artemisinin Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Artemisinin Market Size by Country
  6. 11.2.1 Middle East and Africa Artemisinin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Artemisinin Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Artemisinin Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Artemisinin Value Chain Analysis
  2. 12.1.1 Artemisinin Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Artemisinin Production Mode & Process
  7. 12.2 Artemisinin Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Artemisinin Distributors
  10. 12.2.3 Artemisinin Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst